Skip to main content
Springer logoLink to Springer
. 2022 Apr 7;82(6):717. doi: 10.1007/s40265-022-01714-2

Correction to: Interchangeability of Biosimilars: Overcoming the Final Hurdles

Liese Barbier 1, Arnold G Vulto 1,2,
PMCID: PMC9172654  PMID: 35389202

Correction to: Drugs (2021) 81:1897–1903 10.1007/s40265-021-01629-4

The article “Interchangeability of Biosimilars: Overcoming the Final Hurdles”, written by Liese Barbier, Arnold G. Vulto, was originally published online on the publisher’s internet portal on 2 November 2021 with Open Access under a Creative Commons Attribution Non-Commercial (CC BY-NC 4.0).

After publication in volume 81, issue 16, page 1897–1903 the author(s) decided to cancel the Open Access. Therefore, the copyright of the article changed on 22 March 2022 to © Springer Nature Switzerland AG 2021 with all rights reserved.

The original article has been corrected.

Contributor Information

Liese Barbier, Email: liese.barbier@kuleuven.be.

Arnold G. Vulto, Email: a.vulto@erasmusmc.nl, Email: a.vulto@gmail.com


Articles from Drugs are provided here courtesy of Springer

RESOURCES